New York Botanical Garden

NYBG's endowment pursues a broad strategy that includes buyout, early-stage (seed and start-up), growth, and general venture capital investments. The underlying asset mix is not publicly disclosed, but the mandate spans private equity and venture alongside what is likely a public-equity allocation. Real estate holdings — including the Bronx campus, commercial property in the North Central Bronx, and a Midtown Manhattan education center — form a distinct permanent capital base alongside the financial portfolio.

The precise governance of investment selection — whether through an internal investment office, outsourced chief investment officer, or external fund commitments — has not been publicly detailed. Given the endowment's estimated $398 million size (Altss estimate) and its hybrid venture/buyout strategy, it likely operates through a combination of fund commitments and manager selection overseen by the Board of Trustees' investment committee.

The Garden's 250-acre Bronx campus is city-owned land operated under a public-private partnership, granting permanent location rights without full property-tax exposure. It also holds commercial real estate in the North Central Bronx and a Midtown education center in Manhattan. The William & Lynda Steere Herbarium, the largest in the Western Hemisphere, is a non-financial strategic asset that attracts research grants and international collaborations.

New York City owns the land on which NYBG sits and appoints ex-officio members to the Board of Trustees. This arrangement embeds municipal oversight into the Garden's strategy, meaning long-term capital decisions must reconcile institutional preservation with public-interest obligations. The current mayor or a mayoral designee serves as an ex-officio trustee alongside elected and appointed board members.

While no explicit ESG or mission-related investment policy has been publicly disclosed, the Garden's heavy allocation to venture capital — including early-stage and seed mandates — could potentially target plant-science, biodiversity-technology, or climate-adjacent startups. The presence of the LuEsther T. Mertz Legacy Trust for NYBG suggests at least one dedicated philanthropic vehicle supports the institution alongside the endowment's total-return objectives.

As a 501(c)(3) nonprofit, NYBG's endowment exists to support its tripartite mission as a museum of plants, an educational institution, and a scientific research organization. Beneficiaries include the Garden's 1 million annual visitors, the global scientific community that uses the Steere Herbarium's 7.8 million specimens, and the 250-acre living collection's conservation programs.

Yes. The LuEsther T. Mertz Legacy Trust is a named philanthropic entity tied to the Garden. LuEsther T. Mertz was a major benefactor whose family name also appears on the Mertz Library, which houses one of the world's most significant collections of botanical art, rare books, and folios. This trust likely provides grant-based or endowment income separate from the general investment portfolio.